1 |
Protecting The Aged Heart During Cardiac Surgery: Use of del Nido Cardioplegia Provides Superior Functional Recovery in Isolated HeartsGovindapillai, Arun 07 August 2013 (has links)
The purpose of this study was to determine if del Nido cardioplegia provides superior protection for aged and young adult hearts. We used our isolated working heart model of cardioplegic arrest and reperfusion to compare functional recovery in both senescent and young adult rat hearts, with delivery of del Nido or our standard cardioplegia. In the aged hearts, use of del Nido cardioplegia prevented spontaneous contractions during arrest, reduced troponin release, and provided superior functional recovery during working heart. In contrast, in the young adult hearts, although stroke work was higher in the del Nido group, there were no significant differences in spontaneous activity, troponin release, and cardiac output between del Nido and standard cardioplegia, suggesting that del Nido cardioplegia did not provide superior functional recovery in the young adult heart. Del Nido cardioplegia has the potential to provide superior myocardial protection for elderly patients undergoing cardiac surgery.
|
2 |
Antocianinų poveikis širdies mitochondrijų funkcijoms ir išemijos sukeltai ląstelių žūčiai / Effect of anthocyanins on cardiac mitochondrial functions and ischemia-induced cell deathŠkėmienė, Kristina 18 June 2014 (has links)
Pastaruoju metu daug mokslinių tyrimų atliekama su flavonoidų klasei priskiriamais antocianinais – augaliniais pigmentais, kurie aptinkami uogose, vaisiuose ir daržovėse ir suteikia jiems mėlyną, raudoną ir violetinę spalvas. Literatūroje aprašytas antocianinų poveikis, apsaugantis nuo širdies ir kraujagyslių ligų, siejamas su antocianinų antioksidaciniu veikimu. Mes iškėlėme hipotezę, kad antocianinai gali apsaugoti širdį redukuodami citozolyje esantį citochromą c. Šio darbo tikslas yra ištirti antocianinų poveikį žiurkės širdies mitochondrijų oksidacinio fosforilinimo sistemos efektyvumui bei nustatyti, kokius už ląstelės žūtį atsakingus viduląstelinius signalinius kelius reguliuoja šie junginiai. Iškelti uždaviniai: 1. Ištirti tiesioginį penkių dažniausiai gamtoje sutinkamų antocianinų poveikį žiurkės širdies mitochondrijų kvėpavimui skirtingose metabolinėse būsenose. 2. Nustatyti įvairių antocianinų gebėjimą redukuoti citochromą c in vitro. 3. Nustatyti, ar antocianinai – citochromo c reduktoriai – apsaugo nuo išemijos sukeltų oksidacinio fosforilinimo sistemos pažeidimų ir kaspazių aktyvacijos bei nuo išemijos/reperfuzijos sukeltos kardiomiocitų apoptozės ir nekrozės. 4. Ištirti, ar stipriu citochromą c redukuojančiu aktyvumu pasižymintys antocianinai gali atstatyti mitochondrijų oksidacinio fosforilinimo sistemos efektyvumą po išemijos. 5. Patikrinti, ar tirtųjų antocianinų poveikis širdies mitochondrijų funkcijoms bei apsauginis nuo išemijos ir išemijos/reperfuzijos. / A lot of research is carried out with anthocyanins, which are widely prevalent among colored berries, fruits, and vegetables and give them blue, red, violet, and purple colors. It is known that consumption of dietary plants and products rich in anthocyanins can reduce the risk of cardiovascular diseases. This protective effect is related to the antioxidant properties of anthocyanins. We have raised the hypothesis that anthocyanins could protect cardiomyocytes from ischemia/reperfusion-induced cell death reducing cytosolic cytochrome c. The aim of this work was to investigate the effect of anthocyanins on heart mitochondrial oxidative phosphorylation and determine what intracellular signaling pathways responsible for cell death are regulated by these compounds. The tasks of the study were: 1. To investigate the direct effect of anthocyanins on rat heart mitochondrial respiration rates; 2. To determine the ability of anthocyanins to reduce cytochrome c in vitro; 3. To determine whether anthocyanins – cytochrome c-reducing compounds – protect heart mitochondria from ischemia-induced mitochondrial dysfunction and ischemia/reperfusion-induced cardiomyocyte apoptosis and necrosis; 4. To examine whether anthocyanins with high cytochrome-c reducing activity can restore the efficiency of mitochondrial oxidative phosphorylation after ischemia; 5. To verify whether the effect of the investigated anthocyanins on cardiac mitochondrial function and their protective effect on... [to full text]
|
3 |
Effects of ischemic metabolites and chronic exercise on cardiac myocyte functionHinken, Aaron C., January 2005 (has links)
Thesis (Ph. D.)--University of Missouri-Columbia, 2005. / The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Vita. "May, 2005" Includes bibliographical references.
|
4 |
PHARMACOLOGICAL MODULATION OF SARCOPLASMIC RETICULUM CALCIUM ATPASE AND CALCIUM RELEASE CHANNELS FOR MUSCLE CELL PROTECTIVE ACTIONLv, Yuanzhao 01 December 2015 (has links)
Abnormal homeostasis of intracellular Ca2+ plays a deleterious role in muscle pathologies by triggering processes that lead to dysfunction and necrotic or apoptotic cell death. One pathology where there is significant Ca2+ induced cell damage is ischemia, which initiates further damage (also mediated by Ca2+) generated by the required treatment process of revascularization; namely ischemia-reperfusion injury. Pharmacological agents used therapeutically for cell protection, especially for cardiac protection in ischemic heart diseases, have only directly targeted one of the elements regulating Ca2+ homeostasis, the L-type Ca2+ channels (calcium channel blockers). Other agents, like beta blockers, indirectly target various elements, including sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA) and ryanodine receptors (RyRs). However, there are no pharmacological agents that directly and specifically target these two crucial elements required for intracellular SR Ca2+ homeostasis. Dr. Julio A. Copello’s group has previously studied the cardioprotective agent CGP-37157 (CGP), a benzothiazepine (BZT) derivative of the benzodiazepine (BZD) clonazepam. CGP was previously thought to decrease intracellular SR Ca2+ by acting as a blocker of the mitochondrial Na+/Ca2+ exchanger (Omelchenko et al., 2003). They found, however, that CGP also activates RyRs and inhibits the SERCA, which could better explain the SR effects of the drug (Neumann et al., 2011). These results suggest that drugs inducing partial depletion of SR Ca2+ stores could provide cellular protection in stressful circumstances or processes. The aims of the dissertation were organized based on the two processes that cause damage to muscle cells during ischemia: ischemia and subsequent reperfusion (ischemia-reperfusion injury) (Ibanez et al., 2015). Aim one and two focused on drug-protective action during the ischemic event, while aim three focused on drug protective action in the reperfusion (early post-ischemia) process. In the first Aim, experiments were designed to test the hypotheses that RyRs and/or SERCA could also be the target of i) Drugs with structural similarities to CGP (i.e., other BZTs and some BZDs) and ii) Drug known to confer cellular protection under stressful cellular conditions such as antiepileptic agents. We found that some BZTs (K201, CGP analog) and antiepileptic agents (Sipatrigine and Pimozide) demonstrated potential to prevent SR Ca2+ overload by inhibition of SERCA and, in some cases also by inducing mild activation of RyR channels. These results provided potential mechanisms of action for agents with cell protective action: targeting SERCA and preventing Ca2+ overload in pre-ischemia process. From the results of the first aim, K201 had the most significant effects in both SERCA inhibition and RyRs activation. Therefore, Aim 2 experiments focused on exploring with greater detail the action of the compound K201 on RyRs, SERCA and Ca2+ signaling. We found that K201 is a more potent SERCA blocker than RyR agonist and that SERCA inhibition remains under acidosis mimicking ischemic conditions. In Aim 3, the focus was on testing drugs with potential to prevent the overloaded SR from leaking Ca2+ (via RyRs) upon reperfusion. For that, we have examined various classes of organic polycationic agents in their ability to act as fast and reversible RyRs blockers. Currently, no agent with these characteristics is availableas a therapeutic or has been well defined for use as an experimental drug. The membrane permeable cation DHBP was identified as a potent RyR inhibitor with potential for rapid and transient inhibition of spontaneous SR Ca2+ release during reperfusion. In summary, we have defined the ability of some BZTs and antiepileptic agents (K201, CGP analog, Sipatrigine and Pimozide) to prevent/slow down SR Ca2+ overload by inhibition of SERCA, which may play an important role in their mechanisms of cell protection in ischemic events. In the case of BZT, these drugs may help their cause by producing mild activation of RyR2 channels, In addition, we have identify DHBP as a reversible and fast acting RyR inhibitor with potential as template for development of transient inhibitors of spontaneous SR Ca2+ release which may have significant protective action against injury during early reperfusion of the heart.
|
5 |
Methodological aspects on microdialysis sampling and measurementsAbrahamsson, Pernilla January 2010 (has links)
Background: The microdialysis (MD) technique is widely spread and used both experimentally and in clinical practice. The MD technique allows continuous collection of small molecules such as glucose, lactate, pyruvate and glycerol. Samples are often analysed using the CMA 600 analyser, an enzymatic and colorimetric analyser. Data evaluating the performance of the CMA 600 analysis system and associated sample handling are sparse. The aim of this work was to identify sources of variability related to handling of microdialysis samples and sources of error associated with use of the CMA 600 analyser. Further, to develop and compare different application techniques of the microdialysis probes both within an organ and on the surface of an organ. Material and Methods: Papers I and II are mainly in vitro studies with the exception of the No Net Flux calibration method in paper I where a pig model (n=7) was used to examine the true concentration of glucose and urea in subcutaneous tissue. Flow rate, sampling time, vial and caps material and performance of the analyser device (CMA 600) were examined. In papers III and IV normoventilated anaesthetised pigs (n=33) were used. In paper III, heart ischemia was used as intervention to compare microdialysis measurements in the myocardium with corresponding measurements on the heart surface. In paper IV, microdialysis measurements in the liver parenchyma were compared with measurements on the liver surface in association with induced liver ischemia. All animal studies were approved by the Animal Experimental Ethics Committee at Umeå University Sweden. Results: In paper I we succeeded to measure true concentrations of glucose (4.4 mmol/L) and Urea (4.1 mmol/L) in subcutaneous tissue. Paper II showed that for a batch analyse of 24 samples it is preferred to store microdialysis samples in glass vials with crimp caps. For reliable results, samples should be centrifuged before analysis. Paper III showed a new application area for microdialysis sampling from the heart, i.e. surface sampling. The surface probe and myocardial probe (in the myocardium) showed a similar pattern for glucose, lactate and glycerol during baseline, short ischemic and long ischemic interventions. In paper IV, a similar pattern was observed as in paper III, i.e. data obtained from the probe on the liver surface showed no differences compared with data from the probe in liver parenchyma for glucose, lactate and glycerol concentrations during baseline, ischemic and reperfusion interventions. Conclusion: The MD technique is adequate for local metabolic monitoring, but requires methodological considerations before starting a new experimental serie. It is important to consider factors such as flow rate, sampling time and handling of samples in association with the analysis device chosen. The main finding in this thesis is that analyses of glucose, lactate and glycerol in samples from the heart surface and liver surface reflect concentrations sampled from the myocardium and liver parenchyma, respectively.
|
6 |
Overexpression of CuZnSOD in Coronary Vascular Cells Attenuates Myocardial Ischemia/Reperfusion InjuryChen, Zhongyi, Oberley, Terry D., Ho, Ye Shih, Chua, Chu C., Siu, Brian, Hamdy, Ronald C., Epstein, Charles J., Chua, Balvin H.L. 14 October 2000 (has links)
Superoxide dismutase scavenges oxygen radicals, which have been implicated in ischemia/reperfusion (I/R) injury in the heart. Our experiments were designed to study the effect of a moderate increase of copper/zinc superoxide dismutase (CuZnSOD) on myocardial I/R injury in TgN(SOD1)3Cje transgenic mice. A species of 0.8 kb human CuZnSOD mRNA was expressed, and a 273% increase in CuZnSOD activity was detected in the hearts of transgenic mice with no changes in the activities of other antioxidant enzymes. Furthermore, immunoblot analysis revealed no changes in the levels of HSP-70 or HSP-25 levels. Immunocytochemical study indicated that there was increased labeling of CuZnSOD in the cytosolic fractions of both endothelial cells and smooth muscle cells, but not in the myocytes of the hearts from transgenic mice. When these hearts were perfused as Langendorff preparations for 45 min after 35 min of global ischemia, the functional recovery of the hearts, expressed as heart rate x LVDP, was 48 ± 3% in the transgenic hearts as compared to 30 ± 5% in the nontransgenic hearts (p < .05). The improved cardiac function was accompanied by a significant reduction in lactate dehydrogenase release from the transgenic hearts. Our results demonstrate that overexpression of CuZnSOD in coronary vascular cells renders the heart more resistant to I/R injury.
|
7 |
Scavenger Receptor-A (CD204): A Two-Edged Sword in Health and DiseaseKelley, Jim L., Ozment, Tammy R., Li, Chuanfu, Schweitzer, John B., Williams, David L. 01 January 2014 (has links)
Scavenger receptor A (SR-A), also known as the macrophage scavenger receptor and cluster of differentiation 204 (CD204), plays roles in lipid metabolism, atherogenesis, and a number of metabolic processes. However, recent evidence points to important roles for SR-A in infammation, innate immunity, host defense, sepsis, and ischemic injury. Herein, we review the role of SR-A in infammation, innate immunity, host defense, sepsis, cardiac and cerebral ischemic injury, Alzheimer's disease, virus recognition and uptake, bone metabolism, and pulmonary injury. Interestingly, SR-A is reported to be host protective in some disease states, but there is also compelling evidence that SR-A plays a role in the pathophysiology of other diseases. These observations of both harmful and beneficial effects of SR-A are discussed here in the framework of inflammation, innate immunity, and endoplasmic reticulum stress.
|
8 |
Ischemicko-reperfúzní poškození srdce u chladově adaptovaných potkanů / Ischemia-reperfusion injury in cold acclimated ratsVebr, Pavel January 2016 (has links)
The effect of cold acclimation on body of mammals has been studied for many decades by using relatively low temperatures for acclimation (6-10 řC). The results of these experiments have shown the important role of the adrenergic and thyroid system during acclimation and negative impact on renal system at the same time. In contrast, a recent study on winter swimmers suggests a possibility of positive influence of hardening on cardiovascular system. There is no available study investigating a relationship between cold adaptation and ischemia-reperfusion injury. The aim of this study was to establish a protocol of isolated rat heart and its fixation at our workplace. Furthermore, to find the impact of mild cold acclimation on the ischemia-reperfusion injury of rat. Methods of ex vivo heart perfusion and fixation were successfully established. The effect of 5 weeks long cold acclimation in 10 ± 2 řC on left ventricle ischemia-reperfusion injury was observed. Powered by TCPDF (www.tcpdf.org)
|
9 |
Neonatal Cardiac Fatty Acid MetabolismLam, Victoria Hol Mun Unknown Date
No description available.
|
Page generated in 0.087 seconds